New eczema drug shows promise in Late-Stage trial
NCT ID NCT06477835
First seen Apr 02, 2026 · Last updated Apr 25, 2026 · Updated 4 times
Summary
This study tested a new medicine called SIM0718 for people aged 12 to 75 with moderate to severe eczema (atopic dermatitis) that didn't get better with creams. The trial involved 259 participants and compared the drug to a placebo to see if it improved skin symptoms like redness and itching. The main goals were to measure skin clearance and overall improvement after 16 weeks of treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking University People's Hospital
Beijing, China
Conditions
Explore the condition pages connected to this study.